UnitedHealth's earnings call highlighted strong Q2 2017 performance, with revenue growth exceeding expectations and adjusted earnings per share exceeding guidance.  Management expressed confidence in their ability to continue to grow across all business segments, particularly in Medicare Advantage, potentially gaining market share in 2018.  The focus on cost containment and value-based care, along with an expansive pipeline of opportunities, suggests a positive short-term outlook for the stock.
[1]
